Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study (Q44902367)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study |
scientific article published on September 1, 2003 |
Statements
1 reference
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study (English)
1 reference
Elizabeth Barrett-Connor
1 reference
Paul Miller
1 reference
Ya-Ting Chen
1 reference
Lois E. Wehren
Ethel S. Siris
Thomas A. Abbott
Marc L. Berger
Arthur C. Santora
1 September 2003
1 reference
1 reference
10
1 reference
5
1 reference
412-419
1 reference
Identifiers
1 reference
1 reference